Type 2 Diabetes

Type 2 Diabetes

CRP is currently conducting a clinical research study to evaluate the safety and efficacy of an investigational product for the treatment of type 2 diabetes.

The primary objective of this study is to see how safe an investigational drug is and how well it will work to help people with type 2 diabetes who are currently treated with Metformin. You may qualify for our type 2 diabetes study if you:

–   You must be over the age of 18

–   Have a confirmed diagnosis of type 2 diabetes mellitus within the last 4 years

–   Are currently on a stable dose of Metformin

–   Have a body mass index (BMI) between 25 and 45

Participants who qualify may receive:

–   Study Medication at No Cost

–   Study Related Exams & Lab Work at No Cost

–   Compensation for time and travel may be available

Please Fill out the form

About Type 2 Diabetes (TD2)

People with diabetes don’t respond normally to insulin, the hormone that converts blood sugar to energy. They have insulin resistance. Some common causes for this condition are family history, obesity, and physical inactivity.

Some TD2 symptoms include frequent infections, slow-healing sores, blurred vision, fatigue, unintended weight loss, increased hunger, frequent urination, and increased thirst.

Fill out our form today to see if you qualify!